ReviewMolecular biology reports2025
The importance of ALPK1 kinase functionality as a potential biomarker for inflammatory diseases.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, molecules with the potential to act as biomarkers in the prevention and early diagnosis of diseases are being sought. The above implies that these molecules play key roles in specific stages of the disease or are associated with them. However, before proposing these types of molecules as biomarkers or therapeutic targets, it is essential to thoroughly understand their action mechanism. In this work, the most relevant findings on the function, regulation, disease´s association studies of the ALPK1 protein with kinase activity (α kinase-1) are highlighted. Unlike other protein kinases, ALPK1 specifically recognizes the conformation part of the alpha helix as the phosphorylation site. The objective of this review is to analyze the functions of ALPK1 in different pathologies and to determine whether this protein plays an important role in these diseases, and if it could be used as a biomarker for the progression or prediction of an inflammatory disease.
Indexed as
Identifiers
40493324What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.